Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin

CARBOHYDRATES

Product Details

CAT No.# CS-AH-00169
Category Carbohydrates
CAS NA
Molecular Weight 2131.2
Molecular Formula C98H196O35Si7
Purity: >98%
Synonyms: {[(1R,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31R,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-Tetradecamethoxy-2, 4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacy????
Shipping: Free Shipping for worldwide on order above 2000 USD
Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin Worldwide Suppliers of Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin Carbohydrates Clearsynth CS-AH-00169

Product rating: 9 Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin based on 20 ratings

  1. Carbohydrates
  2. Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)




This page contains information about Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin Cas NA and its Carbohydrates.

Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin Worldwide Suppliers of Heptakis-(6-O-tertbutyl-dimethylsilyl-2,3-di-O-methyl)--cyclodextrin Carbohydrates Clearsynth NA

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."